Unicycive Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Unicycive Therapeutics Depreciation & Amortization Growth & History (UNCY)
Unicycive Therapeutics's depreciation and amortization was $34,000 for fiscal 2025.
View full Unicycive Therapeutics company overviewUnicycive Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $34,000 | $12,000 | +54.55% |
| 2024 | 2024-12-31 | $22,000 | $13,000 | +144.44% |
| 2023 | 2023-12-31 | $9,000 | −$419,000 | −97.90% |
| 2022 | 2022-12-31 | $428,000 | −$40,000 | −8.55% |
| 2021 | 2021-12-31 | $468,000 | $405,000 | +642.86% |
| 2020 | 2020-12-31 | $63,000 | — | — |
Unicycive Therapeutics quarterly depreciation and amortization
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $8,000 | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $151,000 | — | — |
| Q3 2025 | 2025-09-30 | $10,000 | $4,000 | +66.67% |
| Q2 2025 | 2025-06-30 | $6,000 | $6,000 | — |
| Q1 2025 | 2025-03-31 | $8,000 | −$1,000 | −11.11% |
| Q3 2024 | 2024-09-30 | $6,000 | $4,000 | +200.00% |
| Q2 2024 | 2024-06-30 | $0 | −$2,000 | — |
| Q1 2024 | 2024-03-31 | $9,000 | $7,000 | +350.00% |
| Q3 2023 | 2023-09-30 | $2,000 | $1,000 | +100.00% |
| Q2 2023 | 2023-06-30 | $2,000 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $2,000 | −$268,000 | −99.26% |
| Q3 2022 | 2022-09-30 | $1,000 | — | — |
| Q2 2022 | 2022-06-30 | $2,000 | — | — |
| Q1 2022 | 2022-03-31 | $270,000 | — | — |
Unicycive Therapeutics depreciation and amortization trends
Over the last five fiscal years, Unicycive Therapeutics's depreciation and amortization decreased from $63,000 to $34,000, a change of −$29,000. The latest reported quarter, Q2 2026, shows $6,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Unicycive Therapeutics source filings ↗